MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2021

September 17-22, 2021. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • The Functional Impact of REM Sleep Behavior Disorder in Parkinson’s Disease with Mild Cognitive Impairment

    R. Schade, E. Bayram (La Jolla, USA)

  • The Gastrointestinal Dysfunction Scale – Parkinson’s Disease (GIDS-PD): a new tool to assess gastrointestinal dysfunction in Parkinson’s Disease

    M. Camacho, J. Greenland, C. Williams-Gray (Cambridge, United Kingdom)

  • The gender gap in Parkinson’s disease before and after Subthalamic Nucleus Deep Brain Stimulation surgery: preliminary results of a retrospective study.

    A. Trinchillo, F. Vitulli, T. Somma, F. Esposito (Naples, Italy)

  • The Global Parkinson’s Genetics Program (GP2) – a year’s progress

    C. Blauwendraat, A. Noyce, A. Reimer, B. Casey, E. Riley, B. Fiske, M. Rizig, J. Hardy, T. Foroud, K. Murphy, N. Wood, C. Wegel, A. Brice, S. Fox, P. Heutink, R. Krueger, N. Williams, T. Gasser, K. Mok, M. Sharma, K. Marek, T. Sherer, N. Mata, M. Nalls, E. Valente, H. Morris, C. Klein, A. Singleton, T. He-Global-Parkinson’S-Genetics-Program-(gp2) (Bethesda, USA)

  • The Global Parkinson’s Genetics Program (GP2) Underrepresented Populations Working Group

    AF. Schumacher-Schuh, S-Y. Lim, O. Okunoye, S. Bandres-Ciga, P. Heutink, H. Iwaki, R. Kruger, K. Mok, A. Noyce, NU. Okubadejo, M. Rizig, R. Rajan, LK. Prashanth, M. Sharma, J. Shulman, B. Siddiqi, S. Bardien, IF. Mata, GP2. Genetics Project (Porto Alegre, Brazil)

  • The GlyT1 inhibitor bitopertin reduces in the 6-OHDA-lesioned rat model of Parkinson’s disease

    I. Frouni, W. Kang, C. Kwan, D. Bedard, A. Hamadjida, P. Huot (Montreal, Canada)

  • The gut microbiome in Parkinson’s disease: longitudinal insights into disease progression and the use of device-assisted therapies.

    M. Lubomski, X. Xu, A. Holmes, S. Mueller, J. Yang, C. Sue, R. Davis (St Leonards, Australia)

  • The Hauser Diary knowledge test as a tool to improve Rater Training Programs in Parkinson’s disease clinical trials

    C. Mañeru, S. Meyer (Barcelona, Spain)

  • The Huntington’s Disease Structured Interview of Function (HD-SIF): A remotely administered caregiver interview for later stage HD

    M. Roche, R. Fuller, L. Cherneski, O. Handley, S. Capodarca, E. Neacy, S. Frank, G. Stebbins, S. Sathe, C. Sampaio (Princeton, USA)

  • The Impact of Back and Neck Pain in Parkinson’s Disease: The PD-PAIN Study

    D. Shpiner, T. Rundek, H. Li, I. Haq, C. Luca, J. Margolesky, H. Moore, C. Singer (Miami, USA)

  • « Previous Page
  • 1
  • …
  • 117
  • 118
  • 119
  • 120
  • 121
  • …
  • 132
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley